J&J's Erleada prevails over Astellas, Pfizer’s Xtandi in real-world prostate cancer study 0 02.10.2024 21:19 Fiercepharma.com J&J's Erleada prevails over Astellas, Pfizer’s Xtandi in real-world prostate cancer study kdunleavy Wed, 10/02/2024 - 14:19
